HomeTagsMedeze

Tag: Medeze

spot_imgspot_img
Business

Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited

- Offer price of S$0.25 per share is at an attractive premium of 61.3% over the last traded price being 9 May 2025 and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img